Results 51 to 60 of about 199,826 (326)

Efterlevnad av beslut om djurförbud hos hållare av sällskapsdjur och lantbruksdjur i Västra Götalands län [PDF]

, 2013
Denna studie riktar sig främst till länsstyrelsen i Västra Götalands län, som var frågeställare, men också till de andra länsstyrelserna i landet. Syftet var att undersöka hur de personer som på något sätt orsakat lidande hos djur och därför blivit ...
Ringström, Anna
core   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

Molecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He, Chiara Testini, Neda Hekmati, Altea Bonello, Aglaia Schiza, Emmanuel Nwadozi, Mia Phillipson, Carina Strell, Michael Welsh   +8 more
wiley   +1 more source

Verden i endring, diplomati i fatning

Internasjonal Politikk, 2022
De siste tiårene har globalisering og digitalisering gjort verden mindre. «Langt borte eksisterer ikke lenger», som tidligere utenriksminister Thorvald Stoltenberg en gang fastslo.
Kristin Haugevik
doaj   +1 more source

Geopolitiske virkninger av lavutslippssamfunnet [PDF]

, 2015
I denne rapporten presenteres hovedfunn fra ny forskning som belyser geopolitiske virkninger av overgangen til lavutslippssamfunnet og hvilke konsekvenser denne utviklingen har for Norge.
Aaheim, H. Asbjørn, Aakre, Stine, Aamodt, Solveig, Bang, Guri, Glomsrød, Solveig, Gullberg, Anne Therese, Underdal, Arild, Westskog, Hege   +7 more
core  

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Tyvskriminaliteten i Sverige og Norge 1935-1954.

Nordisk Tidsskrift for Kriminalvidenskab, 1956
Intet ...
Knut Sveri
doaj   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

Molecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad, Marie Austdal, Oddmund Nordgård, Gunnar Mellgren, Satu Oltedal, Marie L. Austbø, Ylva H. Vignes, Thomas Helland, Kristin Jonsdottir, Tone H. Lende, Emilius A. M. Janssen, Bjørnar Gilje, Kjersti Tjensvoll, PBCB study group, Gunnar Mellgren, Tone Hoel Lende, Anette Heie, Kristin Viste, Anita Røyneberg Alvheim, Emiel AM Janssen, Kristin Jonsdottir, Ann Cathrine Kroksveen, Thomas Helland, Einar Gudlaugsson, Oddmund Nordgård, Satu Oltedal, Kristin Løge Aanestad, Jan Terje Kvaløy, Kirsten Lode, Kari Britt Hagen, Marie Austdal, Ylva H. Vignes, Siri Tungland Sola, Nina Egeland Amundsen, Finn Magnus Eliassen, Emeritus Ernst A Lien   +35 more
wiley   +1 more source

Norske straffedommer 1954.

Nordisk Tidsskrift for Kriminalvidenskab, 1956
Intet ...
Trygve Leivestad
doaj   +1 more source

Rusmidler i Norge 2009 [PDF]

, 2009
Rusmidler i Norge inneholder oppdaterte tabeller om forbruk, økonomi, kriminalitet, skadevirkninger og behandling knyttet både til alkohol-, narkotika-, legemiddel- og tobakksbruk.
Bryhni, Anders, Bye, Elin Kristin, Edland-Gryt, Marit, Horverak, Øyvind, Lund, Marianne, Skretting, Astrid   +5 more
core  

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

Molecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli, Alessio Bevilacqua, Mathias Wenes, Denis Migliorini, Lars van der Veen, Sigrid S Skånland, Giusy Di Conza, Kjetil Taskén   +7 more
wiley   +1 more source